These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 3111860)
1. "In vivo" activated splenic T cells are refractory to interleukin 2 growth "in vitro". Bandeira A; Larsson EL; Forni L; Pereira P; Coutinho A Eur J Immunol; 1987 Jul; 17(7):901-8. PubMed ID: 3111860 [TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro expression of an interleukin 2 receptor by murine B and T lymphocytes. Finkelman FD; Malek TR; Shevach EM; Mond JJ J Immunol; 1986 Oct; 137(7):2252-9. PubMed ID: 3093569 [TBL] [Abstract][Full Text] [Related]
3. Involvement of soluble mediator(s) different from interleukin (IL) 1 in the antigen-induced IL 2 receptor expression and proliferation of L3T4+ (CD4+) T lymphocytes. Germann T; Schmitt E; Huhn H; Rüde E Eur J Immunol; 1988 Mar; 18(3):459-65. PubMed ID: 3128448 [TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of immature (Lyt-2-/L3T4-) thymocytes. Identification of four major phenotypically distinct subsets differing in cell cycle status and in vitro activation requirements. Howe RC; MacDonald HR J Immunol; 1988 Feb; 140(4):1047-55. PubMed ID: 3257768 [TBL] [Abstract][Full Text] [Related]
5. Interleukin 2 receptor expression and interleukin 2 production in exponentially growing T cells: major differences between in vivo and in vitro proliferating T lymphocytes. Rocha B; Lembezat MP; Freitas A; Bandeira A Eur J Immunol; 1989 Jun; 19(6):1137-45. PubMed ID: 2568931 [TBL] [Abstract][Full Text] [Related]
6. IL-4/B cell stimulatory factor 1 stimulates T cell growth by an IL-2-independent mechanism. Brown M; Hu-Li J; Paul WE J Immunol; 1988 Jul; 141(2):504-11. PubMed ID: 3133410 [TBL] [Abstract][Full Text] [Related]
7. Murine lymphocytes exhibit heterogeneity in their proliferative responsiveness to calcium ionophore. Kakkanaiah VN; Nagarkatti PS; Nagarkatti M Cell Mol Biol (Noisy-le-grand); 1992; 38(5-6):533-43. PubMed ID: 1483106 [TBL] [Abstract][Full Text] [Related]
8. Changing patterns of lymphocyte proliferation, IL-2 production and utilization, and IL-2 receptor expression in mice infected with Schistosoma mansoni. Yamashita T; Boros DL J Immunol; 1990 Jul; 145(2):724-31. PubMed ID: 1973188 [TBL] [Abstract][Full Text] [Related]
9. Radiosensitivity and responsiveness to recombinant interleukin-2 of effector cells of graft vs. host disease and mixed lymphocyte reaction in mice. Stark J; Weiss L; Slavin S Isr J Med Sci; 1992 Nov; 28(11):767-72. PubMed ID: 1468887 [TBL] [Abstract][Full Text] [Related]
10. Activation requirements for normal T cells: accessory cell-dependent and -independent stimulation by anti-receptor antibodies. Bekoff M; Kubo R; Grey HM J Immunol; 1986 Sep; 137(5):1411-9. PubMed ID: 3489033 [TBL] [Abstract][Full Text] [Related]
11. Lack of intermediate-affinity interleukin-2 receptor in mice leads to dependence on interleukin-2 receptor alpha, beta and gamma chain expression for T cell growth. Chastagner P; Moreau JL; Jacques Y; Tanaka T; Miyasaka M; Kondo M; Sugamura K; Thèze J Eur J Immunol; 1996 Jan; 26(1):201-6. PubMed ID: 8566067 [TBL] [Abstract][Full Text] [Related]
12. Activated T lymphocytes from mice infected by lymphocytic choriomeningitis virus display high affinity IL-2 receptors but do not proliferate in response to IL-2. Saron MF; Colle JH; Dautry-Varsat A; Truffa-Bachi P J Immunol; 1991 Dec; 147(12):4333-7. PubMed ID: 1753103 [TBL] [Abstract][Full Text] [Related]
13. Autoreactivity accelerates the development of autoimmunity and lymphoproliferation in MRL/Mp-lpr/lpr mice. Weston KM; Yeh ET; Sy MS J Immunol; 1987 Aug; 139(3):734-42. PubMed ID: 3110283 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms by which accessory cells contribute in growth of resting T lymphocytes initiated by OKT3 antibody. Palacios R Eur J Immunol; 1985 Jul; 15(7):645-51. PubMed ID: 3924633 [TBL] [Abstract][Full Text] [Related]
15. Augmentation of in vitro interleukin 10 production after in vivo administration of interleukin 18 is activated macrophage-dependent and is probably not involved in the antitumor effects of interleukin 18. Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Ikegami H; Kurimoto M Anticancer Res; 1998; 18(6A):4267-74. PubMed ID: 9891477 [TBL] [Abstract][Full Text] [Related]
16. Restricted expression of mitogen-induced high affinity IL-2 receptors in aging mice. Proust JJ; Kittur DS; Buchholz MA; Nordin AA J Immunol; 1988 Dec; 141(12):4209-16. PubMed ID: 3264308 [TBL] [Abstract][Full Text] [Related]
17. Selective immunosuppression with anti-interleukin 2 receptor-targeted therapy: helper and suppressor cell activity in rat recipients of cardiac allografts. Kupiec-Weglinski JW; Padberg W; Uhteg LC; Ma L; Lord RH; Araneda D; Strom TB; Diamantstein T; Tilney NL Eur J Immunol; 1987 Mar; 17(3):313-9. PubMed ID: 2952511 [TBL] [Abstract][Full Text] [Related]
18. Two different molecular pathways account for low IL-2 receptor and c-myc mRNA expression by lpr Lyt-2- L3T4- T cells. Katagiri K; Katagiri T; Yokota S; Eisenberg RA; Cohen PL; Ting JP J Immunol; 1988 Sep; 141(6):2145-52. PubMed ID: 3139753 [TBL] [Abstract][Full Text] [Related]
19. Isolated peripheral T cells from GvHR recipients exhibit defective IL-2R expression, IL-2 production, and proliferation in response to activation stimuli. Levy RB; Jones M; Cray C J Immunol; 1990 Dec; 145(12):3998-4005. PubMed ID: 1979582 [TBL] [Abstract][Full Text] [Related]
20. Analysis of isolated and combined effects of calcium ionophore and phorbol ester on T lymphocyte activation. Nóbrega AF; Maldonado MS; Dos Reis GA Clin Exp Immunol; 1986 Sep; 65(3):559-69. PubMed ID: 3096619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]